Methotrexate Inhibits Proliferation but Not Interleukin 1 Stimulated Secretory Activities of Cultured Human Synovial Fibroblasts

Overview

Journal J Rheumatol

Specialty Rheumatology

Date 1993 Feb 1

PMID 8474058

Citations 8

Authors

F A Meyer

I Yaron

V Mashiah

M Yaron

Affiliations

Soon will be listed here.

Abstract

The effect of methotrexate (MTX) on proliferation and on interleukin 1 stimulated secretory activities of human synovial fibroblasts in culture was investigated. MTX caused a dose dependent inhibition of growth over the concentration range 0.07-2.2 microM with a half-maximal effect at 0.37 microM. INhibition was competitively relieved by coaddition of leucovorin. Cell growth was fully restored after MTX pretreatment of 24 h but not after 48 h, even on subsequent leucovorin addition. Cell viability was unaffected by MTX treatment. MTX had no effect on interleukin 1 stimulated production of prostaglandin E, hyaluronic acid and collagenase. Our results raise the possibility that one of the mechanisms contributing to the therapeutic effects of MTX in patients with rheumatoid arthritis may involve modulation of synovial fibroblast growth.

Citing Articles

Methotrexate modulates the expression of MMP-1 and type 1 collagen in dermal fibroblast.

Nabai L, Kilani R, Aminuddin F, Li Y, Ghahary A Mol Cell Biochem. 2015; 409(1-2):213-24.

PMID: 26298287 DOI: 10.1007/s11010-015-2526-8.

Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue.

Gheorghe K, Sadique S, Leclerc P, Idborg H, Wobst I, Catrina A Arthritis Res Ther. 2012; 14(3):R121.

PMID: 22616846 PMC: 3446502. DOI: 10.1186/ar3851.

Good clinical response to methotrexate treatment in a patient with fibroblastic rheumatism.

Paupitz J, de Carvalho J Rheumatol Int. 2010; 32(6):1789-91.

PMID: 20340022 DOI: 10.1007/s00296-010-1433-2.

Administration of PDE4 inhibitors suppressed the pannus-like inflammation by inhibition of cytokine production by macrophages and synovial fibroblast proliferation.

Kobayashi K, Suda T, Manabe H, Miki I Mediators Inflamm. 2008; 2007:58901.

PMID: 18274640 PMC: 2233982. DOI: 10.1155/2007/58901.

Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis.

Hildner K, Finotto S, Becker C, Schlaak J, Schirmacher P, Galle P Clin Exp Immunol. 1999; 118(1):137-46.

PMID: 10540171 PMC: 1905404. DOI: 10.1046/j.1365-2249.1999.01022.x.